Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria

British Journal of Clinical Pharmacology

Volumn 45, Issue 4, 1998, Pages 347-354

  Sidhu, J S ^a   Ashton, M ^a,c   Huong, N V ^b   Hai, T N ^b   Karlsson, M O ^a   Sy, N D ^b   Jonsson, E N ^a   Cong, L D ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Inst Malariology   (Viet Nam)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Artemisinin; Capillary blood; Malaria; Paediatrics; Population pharmacokinetics

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; DIAZEPAM; FANSIDAR; PARACETAMOL; THIAMINE;

ADULT; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CHILD; CLINICAL TRIAL; DRUG BIOAVAILABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PARASITE; PRIORITY JOURNAL; PROTOZOAL INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; FEMALE; HALF-LIFE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SESQUITERPENES;

EID: 0031886621     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00686.x     Document Type: Article

References (23)

1. Fischer PR. Tropical pediatrics. Pediatr Rev 1993; 14: 95-99.
2. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-608.
3. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitology 1993; 76: 85-95.
4. Ashton M, Sy ND, Gordi T, et al. Evidence for time-dependent artemisinin kinetics in adults with uncomplicated malaria. Pharm Pharmacol Lett 1996; 6: 127-130.
5. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB, Bjôrkman A. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans Roy Soc Trop Med Hyg 1996; 90: 61-65.
6. Boreus LO. The role of therapeutic drug monitoring in children. Clin Pharmacokinet 1989; 17: 4-12.
7. Sidhu JS, Ashton M. Single-dose, comparative study of venous, capillary and salivary artemisinin concentrations in healthy, male adults. Am J Trop Med Hyg 1997; 56: 13-16.
8. World Health Organisation. Severe and complicated malaria. Trans Roy Soc Trop Med Hyg 1990; 84 (Suppl 2): 1-65.
9. Ashton M, Sy ND, Huong NV, et al. Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clin Pharmacol Ther 1998 (in press).
10. Beal SL, Sheiner LB. NONMEM User's Guide. University of California, San Francisco, NONMEM Project Group, 1992.
11. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977; 5: 445-479.
12. Schoemaker RC, Cohen AF. Estimating impossible curves using NONMEM. Br J Clin Pharmacol 1996; 42: 283-290.
13. Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm 1993; 21: 735-750.
14. Ette EI, Ludden TM. Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 1995; 12: 1845-1855.
15. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. J Pharmacokinet Biopharm 1992; 20: 511-528.
16. Boeckmann AJ, Sheiner LB, Beal SL. NONMEM User's Guide. University of California, San Francisco, NONMEM Project Group, 1992.
17. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB, Bjôrkman A. Clinical efficacy and phannacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria, Br J Clin Pharmacol 1996; 41: 587-592.
18. Wade JR, Kelman AW, Howie CA, Whiting B. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis. J Pharmacokinet Biopharm 1993; 21: 209-222.
19. Crom WR. Pharmacokinetics in the child. Environ Health Perspect 1994; 102 (Suppl 11): 111-118.
20. Evans WH, Petros WP, Relling MV, et al. Clinical pharmacology of cancer chemotherapy in children. Pediatr Clin North Am 1989; 36: 1199-1230.
21. Crom WR, Relling MV, Christensen ML, Rivera GK, Evans WE. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine. Clin Pharmacal Ther 1992; 50: 132-140.
22. Ellis EF, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58: 542-547.
23. White NJ. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet 1985; 10: 187-215.